Health — Page 6
- FDA pilot fast-tracks up to 10 IND drug programs
- England’s Waterways Fail to Meet Essential Chemical Safety Standards
- Scientists Find Blood Test Predicting Dementia 10 Years Early
- Semaglutide Cut Calorie Intake for 60 Weeks in Trial
- South Australia confirms H5 bird flu on Limestone Coast
- Moderna mRNA Flu Vaccine Approved for Adults 50+
- Hybrid Diet Strategy for Longevity and Metabolic Health
- Doctors Target Midlife Care to Delay Dementia Onset
- Phase 3 Trial Shows Bepirovirsen Cures 20% of Hepatitis B Cases
- Montana Finalizes Rules for Non-FDA Approved Drug Sales
- African Nations Pledge $45M to WHO Funding Initiative
- Youth Vapes Fill With Potent Synthetic Cannabinoids
- Gene editing advances raise new bioethics questions
- GLP-1 Drugs Tied to Higher Alopecia Risk in Study
- Chipotle Removes Jalapeños Amid Salmonella Probe
- DR Congo Ebola Death Toll Surpasses 1,700
- US Youth Turn to AI Chatbots for Unsupervised Therapy
- Sleep EEG AI estimates brain age to flag dementia risk
- Chile mummy DNA links smallpox arrival to Europeans
- Antarctica temperature swings set new cold and warm marks
- Measles outbreak moves Kennedy toward vaccine message shift
- Qatar Funds $4M Flexible WHO Support for Global Health
- Bird Flu Outbreak Expands Across Southern Australia
- Study links protein restriction to healthier aging signals
- Subzero kidney storage keeps organs viable for 72 hours
- Saudi Arabia Commits $517.7 Million to Global Health and Humanitarian Initiatives
- African Union, WHO renew health cooperation framework
- Progestogen contraceptives tied to higher meningioma risk
- US Measles Vaccination Urged as Cases Hit 35
- Virunga National Park Establishes Ebola Screenings to Curb Outbreak
- Ebola Outbreak in Congo Escalates Into Regional Health Crisis
- Pennsylvania measles cases drive new baby vaccine rules
- VA semaglutide trial enrolls 600 veterans for 28 weeks total
- Cyclosporiasis Outbreak Spreads Across 45 US States
- FDA Reviews Generic Tirzepatide Applications Amid Ongoing Patent Protections
- FDA approves Simtriyo for ADHD in ages 6 and older
- French Firefighters Struggle to Contain Gironde Wildfires
- CRISPR gene therapy Casgevy shows sickle cell success
- Stroke risk factors rise faster among Black Londoners
- FDA Approves First Oral PCSK9 Inhibitor for LDL Cholesterol Management